Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;60(6):1825-31.
doi: 10.1007/s10620-015-3529-8. Epub 2015 Feb 24.

Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease

George Boon-Bee Goh  1 , Mangesh R Pagadala, Jaividhya Dasarathy, Aynur Unalp-Arida, Rish K Pai, Lisa Yerian, Amer Khiyami, Achuthan Sourianarayanane, Ruth Sargent, Carol Hawkins, Srinivasan Dasarathy, Arthur J McCullough
Affiliations

Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease

George Boon-Bee Goh et al. Dig Dis Sci. 2015 Jun.

Abstract

Background and aim: While histological differences have been reported between pediatric and adult nonalcoholic fatty liver disease (NAFLD), potential age-related changes in serum transaminases and liver histology remain largely unexplored. Our study sought to investigate the clinical and histological characteristics of NAFLD across age.

Methods: This was a prospective cross-sectional study of 502 biopsy-proven NAFLD patients. Clinical data were evaluated and compared among different age groups; group A (ages 18-44), B (ages 45-64), and C (≥ ages 65).

Results: 34.9, 56.0, and 9.1 % of the cohort were distributed among group A, B, and C, respectively. While the prevalence of nonalcoholic steatohepatitis (NASH) was comparable across age groups, the prevalence of advanced fibrosis increased with age (p = 0.000). Although the mean ALT progressively decreased with age; 87, 64, 56 U/L in group A, B, and C, respectively (p = 0.000), there was no difference in mean AST (p = 0.939) across age. The AST:ALT ratio (AAR) progressively increased from 0.7, 0.9, and 1.1 in group A, B, and C, respectively (p = 0.000). In group C, an AAR ≥ 1 was found in 74 and 40 % of patients with and without advanced fibrosis.

Conclusion: With advancing age, ALT levels progressively declined while AST levels remained stable, leading to a higher AAR. Although higher AAR is often used as a surrogate measure of advanced fibrosis, advancing age can also contribute to increased AAR. In fact, an AAR ≥ 1 was found in significant number of elderly patients without advanced fibrosis. Consequently, an increased AAR may be a function of decreasing ALT with age in addition to progressive fibrosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82 - PubMed
    1. Hepatology. 2013 Nov;58(5):1644-54 - PubMed
    1. Exp Gerontol. 2013 Aug;48(8):705-9 - PubMed
    1. Hepatology. 2010 Sep;52(3):913-24 - PubMed
    1. Gut. 2008 Oct;57(10):1441-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources

  NODES
admin 1
Association 1
twitter 2